109 related articles for article (PubMed ID: 7691368)
1. Autoreactivity in patients with Behçet's disease.
Taylor PV; Chamberlain MA; Scott JS
Br J Rheumatol; 1993 Oct; 32(10):908-10. PubMed ID: 7691368
[TBL] [Abstract][Full Text] [Related]
2. Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
Aydinoglu-Candan Ö; Araz-Erşan B; Gul A; Badur S; Tugal-Tutkun I
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):457-65. PubMed ID: 25500983
[TBL] [Abstract][Full Text] [Related]
3. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
[TBL] [Abstract][Full Text] [Related]
4. Infliximab treatment-induced formation of autoantibodies is common in Behçet's disease.
Elezoglou A; Kafasi N; Kaklamanis PH; Theodossiadis PG; Kapsimali V; Choremi E; Vaiopoulos G; Sfikakis PP
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S65-9. PubMed ID: 17949554
[TBL] [Abstract][Full Text] [Related]
5. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.
Bassyouni IH; Gamal S; Talaat RM; Siam I
Mod Rheumatol; 2014 Mar; 24(2):316-20. PubMed ID: 24593207
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
Kang HJ; Lee YW; Han SH; Cho HC; Lee KM
J Korean Med Sci; 1998 Aug; 13(4):400-4. PubMed ID: 9741545
[TBL] [Abstract][Full Text] [Related]
8. [Antiphospholipid antibodies in Behcet's disease].
Alekberova ZS; Prokaeva TB; Reshetniak TM; Aleksandrova EN; Nasonov EL
Klin Med (Mosk); 2000; 78(5):37-8. PubMed ID: 10881508
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
[TBL] [Abstract][Full Text] [Related]
10. Are the specific and nonspecific ANA staining patterns of Behçet's Disease patients important?
Ilhan F; Aksoy R; Tutkak H
Reumatol Clin (Engl Ed); 2022 Mar; 18(3):147-149. PubMed ID: 35277212
[TBL] [Abstract][Full Text] [Related]
11. Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Lee JH; Cho SB; Bang D; Oh SH; Ahn KJ; Kim J; Park YB; Lee SK; Lee KH
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S63-6. PubMed ID: 19796536
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Borrelia burgdorferi in patients with Behçet's disease.
Onen F; Tuncer D; Akar S; Birlik M; Akkoc N
Rheumatol Int; 2003 Nov; 23(6):289-93. PubMed ID: 12682785
[TBL] [Abstract][Full Text] [Related]
13. Identification of prohibitin as an antigen in Behcet's disease.
Xun Y; Chen P; Yan H; Yang W; Shi L; Chen G; Du H
Biochem Biophys Res Commun; 2014 Aug; 451(3):389-93. PubMed ID: 25091478
[TBL] [Abstract][Full Text] [Related]
14. Identification of hnRNP C1/C2 as an Autoantigen in Patients with Behcet's Disease.
Hussain M; Xiao J; Zhang Y; Chen P; Du H
Iran J Immunol; 2018 Jun; 15(2):133-141. PubMed ID: 29947342
[TBL] [Abstract][Full Text] [Related]
15. Anti-cardiolipin and anti-Neutrophil Cytoplasmic Antibodies in Iranian patients with Behcet's disease.
Ataollahi MR; Aflaki E; Nazarinia MA; Shenavandeh S; Habibagahi Z; Gharesi-Fard B; Kamali-Sarvestani E
Iran J Immunol; 2012 Dec; 9(4):241-7. PubMed ID: 23268290
[TBL] [Abstract][Full Text] [Related]
16. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia.
Chan CC; Palestine AG; Nussenblatt RB; Roberge FG; Benezra D
Ophthalmology; 1985 Aug; 92(8):1025-8. PubMed ID: 3900848
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease.
Vural B; Sehitoğlu E; Cavuş F; Yalçınkaya N; Haytural H; Küçükerden M; Ulusoy C; Uğurel E; Turan S; Bulut L; Türkoğlu R; Shugaiv E; Kürtüncü M; Atakan S; Güre AO; Gül A; Eraksoy M; Akman-Demir G; Tüzün E
J Neuroimmunol; 2013 Oct; 263(1-2):139-44. PubMed ID: 24035008
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
[TBL] [Abstract][Full Text] [Related]
20. Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity?
Prado LL; Goncalves CR; Viana VT; Saad CGS; Bonfa E
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):28-32. PubMed ID: 29465373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
